Abstracts

MPOX DNA CLEARANCE IN SEMEN OVER SIX MONTHS FOLLOW-UP

Background: During mpox outbreak, sexual intercourse demonstrates to be a well-established way of transmission. WHO recommends avoiding any sexual contact among mpox cases during the 21-days monitoring period, regardless of their symptoms. However, it is unknown whether seminal fluids might represent a viral reservoir. Therefore, we aimed at evaluating mpox DNA clearance in semen samples…

UNRAVELING ONGOING INFLAMMATION AFTER EARLY ART BY IN-DEPTH ANALYSIS OF LYMPH NODES

Background: Antiretroviral therapy (ART) initiation during acute HIV-1 infection limits HIV reservoir seeding and favors immune restoration, however there are concerns of remaining increased systemic inflammation, despite intervention with very early ART. In-depth analysis of lymph nodes during and after acute HIV-infection, may provide insight into the drivers of this inflammation. Methods: Samples were selected…

WEIGHT GAIN FOLLOWING SWITCH TO DOLUTEGRAVIR AMONG ADULT HIV COHORTS IN WEST AFRICA

Background: Following WHO recommendations, most countries have transitioned to Dolutegravir (DTG)-based regimens as first-line antiretroviral therapy (ART). Despite documented adverse metabolic effects from developed countries, limited information is available from resource-limited settings. We explored changes in body weight before and after switch to a DTG-based regimen and assessed the association between switch to DTG and…

A RANDOMIZED CONTROL TRIAL OF AN HIV CARE INTERVENTION BUNDLE FOR PEOPLE WITH HIV

Background: Prompt initiation of antiretroviral therapy (ART) is now considered the standard of HIV care. Factors associated with delayed or inconsistent HIV care HIV care include: poverty, lack of transportation, lack of healthcare coverage and fear of HIV stigma. Strengths-based case management, intensive outreach, and patient navigation are well-supported interventions to improve care that have…

TRENDS IN PERSISTENT HIV VIREMIA DURING UNIVERSAL TEST-AND-TREAT SCALE-UP IN UGANDA

Background: Universal Test and Treat (UTT) has expanded antiretroviral therapy (ART) access globally, but population-based studies of longitudinal HIV treatment outcomes following UTT are rare. We characterized population-level trends in durable HIV viral load suppression (VLS) and persistent and intermittent viremia after UTT scale-up in Rakai, Uganda. Methods: We ascertained viral load status among Rakai…